Navigation Links
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2011
Date:1/26/2011

ers in the Other category were $22 million, up from the year-ago quarter when the company reversed a $62 million order in Sweden for a proton therapy system.  Excluding the proton order reversal, first quarter net orders for the Other category were even with the year-ago period.

Outlook "We continue to believe that annual revenues for fiscal 2011 will grow 10 to 11 percent over the fiscal 2010 total," said Guertin.  "Given our improved margins and the strength of our earnings in the first quarter, we now believe that net earnings per diluted share for fiscal year 2011 could grow to a range of $3.39 to $3.45.  For the second quarter of fiscal 2011, we believe that total company revenues could increase by about 9 to 10 percent over the prior year period and that net earnings per diluted share could be in the range of $0.83 to $0.86."

Investor Conference CallVarian Medical Systems is scheduled to conduct its first quarter fiscal year 2011 conference call at 2 p.m. PT today.  To hear a live webcast or replay of the call, visit the investor relations page on the company's web site at www.varian.com/investor where it will be archived for a year.  To access the call via telephone, dial 1 800 901-5226 from inside the U.S. or 1-617-786-5413 from outside the U.S. and enter confirmation code 58660413.  The replay can be accessed by dialing 1 888 286-8010 from inside the U.S or 1-617-801-6888 from outside the U.S. and entering confirmation code 98071883.  The telephone replay will be available through 5 p.m. PT, Friday, January 28, 2011.

For automatic "e-mail alerts" regarding Varian news, events, and new investor materials on the website, investors can subscribe on the company website:  http://varian.investorroom.com/index.php?s=58. For additional information, contact investor relations at 1 650 424-5834.'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... DIEGO , Dec. 18, 2014  RESMED INC. (NYSE: ... its second quarter of fiscal year 2015 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
(Date:12/19/2014)... , Dec. 18, 2014   Aratana Therapeutics, ... biopharmaceutical company focused on the licensing, development and ... announced positive results from its pivotal field study ... treating pain in dogs with osteoarthritis.  In the ... assessment scores that were statistically significant compared to ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... and Volcano Corporation (NASDAQ: VOLC ), a global ... today announced that they have entered into a definitive merger ... offer to acquire all of the issued and outstanding shares ... equity purchase price of USD 1 billion (approx. EUR 800 ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... Hospitals spend more each year on medical devices and ... than they would if purchased in the open-market according ... Manufacturers Association (MDMA).  The study empirically shows that GPOs ... them to receive kickbacks from suppliers, and that they ...
... 6 Ferring Pharmaceuticals Inc. today announced publication ... of LYSTEDA™ (tranexamic acid) tablets for cyclic heavy ... the peer-reviewed journal, Obstetrics & Gynecology . ... reduced menstrual blood loss from baseline, and improved ...
Cached Medicine Technology:GPOs Fail to Provide Hospitals and Patients Health Care Savings 2Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 2Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 3Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 4
(Date:12/21/2014)... Khanna Vision Institute is pleased to ... Aspen Helicopters holiday event for underprivileged kids. The highlight ... flown by an aspen helicopter pilot. In the cover ... sleigh was visible.(please see accompanying video). Helicopter pilots require ... helped many pilots with Pi in eye vision correction. ...
(Date:12/21/2014)... Recently, one of the best prom dresses ... has introduced its new collection of 2015 prom ... on all its prom dresses & other fashionable designs, ... providing top quality dress products and great customer services ... one of the best prom dresses online shops around ...
(Date:12/21/2014)... Tiburon, CA (PRWEB) December 21, 2014 ... and resolved performance issues in hundreds of emergency departments ... patient satisfaction. Its findings have been translated into an ... hospital leaders to correct deficiencies and enhance the patient ... of outsourced emergency physician staffing and management services for ...
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation ... and Whittier offices. The Hope for the Holidays Toy Drive ... and their families during the holiday season. This year, the ... children between both offices. This event continues to be successful ... service team, store managers and assistant managers came out and ...
(Date:12/20/2014)... Weddingshe.com has recently announced its new collection of sweet ... occasion dresses for the coming new year. , ... for global women. Now, all the models on its ... off. Among the new items, the model of 10986064 ... very popular. What’s more, Weddingshe.com also provides a fast ...
Breaking Medicine News(10 mins):Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2
... to low back pain, physicians generally advise exhausting nonsurgical ... shows that for degenerative spondylolisthesis with spinal stenosis, ... ,Degenerative spondylolisthesis is a condition in which breakdown ... causes one vertebra to slip over the one below. ...
... potentially lethal to humans, had been found in a flock of ... ,The presence of H5N1 bird flu was confirmed on ... (2.5 miles) from a farm where some 6,000 turkeys were slaughtered ... farm in Tisova was the first incidence of H5N1 bird flu ...
... Zealand cabinet Thursday agreed to ban popular "party pills" and ... year, Associate Health Minister Jim Anderton said. ... clubbers and partygoers and are widely sold in specialist "party ... ,Anderton said he hoped Parliament would pass legislation to ...
... to a smiling Marilyn Monroe or feeling the muscles of ... on Wednesday unveiled a system that enables you to feel ... glove. ,The "tangible 3D" system creates graphics that ... glove that allows users to "feel" them, according to NTT ...
... United States added farm-raised fish and shrimp to a growing ... said Thursday. ,The US Food and Drug ... seafood until importers could prove the shipments were free of ... lawmakers urged a recall of up to 450,000 Chinese tires ...
... Personality, Evaluation and Psychological Treatment of the University of ... variables such as erotophilia (positive attitude towards sexuality), ... in human beings. ,The researcher Juan Carlos ... and valid instruments in Spain to evaluate sexual desire. ...
Cached Medicine News:Health News:Surgery- Very Effective for Common Back Pain 2Health News:Surgery- Very Effective for Common Back Pain 3Health News:Potentially Lethal H5N1 Bird Flu Resurfaces in Europe 2Health News:US to Detain Seafood Imports from China 2Health News:Sexual Fantasies Play an Important Role in Boosting Desire 2Health News:Sexual Fantasies Play an Important Role in Boosting Desire 3
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
... With the Hertel, the ... hands and held firmly against ... line with the center of ... against the two temporal orbital ...
Hertel exophthalmometer is used for precise exophthalmos measurements (e.g. exophthalmic goiter)....
Naugle exophthalmometer is superior and inferior orbital rim-based instrument....
Medicine Products: